Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
06/14/2012 | WO2012078792A2 Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
06/14/2012 | WO2012078787A1 Molecular targets for als and related disorders |
06/14/2012 | WO2012078773A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a |
06/14/2012 | WO2012078752A2 Serine protease inhibitor kazal antibodies |
06/14/2012 | WO2012078717A1 Biomarkers for breast cancer patients |
06/14/2012 | WO2012078710A1 Nucleic acid target detection using a detector, a probe and an inhibitor |
06/14/2012 | WO2012078618A2 Predicting and treating diabetic complications |
06/14/2012 | WO2012078602A2 Method for diagnosis and method of treatment of autism spectrum disorders and intellectual disability |
06/14/2012 | WO2012078558A2 microRNAs AS NEW THERAPEUTIC TARGETS FOR THE PREVENTION AND/OR TREATMENT OF RETINOPATHY |
06/14/2012 | WO2012078540A1 Modulating immune cell activity using cytokine-induced src homology 2 and/or high temperature requirement a-1 |
06/14/2012 | WO2012078470A2 Methods of small molecule directed regeneration from pluripotent stem cells |
06/14/2012 | WO2012078426A2 Microorganism concentration process and device |
06/14/2012 | WO2012078374A2 Microorganism concentration process and device |
06/14/2012 | WO2012078321A1 Phased genome sequencing |
06/14/2012 | WO2012078308A1 Devices and methods for concentration and analysis of fluids |
06/14/2012 | WO2012078288A2 Methods of determining risk of adverse outcomes in acute myeloid leukemia |
06/14/2012 | WO2012078248A1 Gelatinous substance based growth medium filtration device and method |
06/14/2012 | WO2012078209A1 Diagnosis and treatment of adrenocortical tumors using human microrna-483 |
06/14/2012 | WO2012078138A1 Cell array quality control device for pathological analysis |
06/14/2012 | WO2012078053A1 Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder |
06/14/2012 | WO2012077898A2 Metabolic diseases-related odorant receptor genes and use thereof |
06/14/2012 | WO2012077819A1 Method and kit for detecting target nucleic acid |
06/14/2012 | WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same |
06/14/2012 | WO2012077105A2 Biomarkers for detecting a cancerous state in a subject |
06/14/2012 | WO2012076980A1 Phytophthora resistance in sweet peppers |
06/14/2012 | WO2012076943A1 Biomarker for detecting high-altitude adaptation and high-altitude pulmonary edema |
06/14/2012 | WO2012076922A1 Method of identifying a subject having or at risk of having or developing a multiple sclerosis |
06/14/2012 | WO2012076846A1 Polymorphism |
06/14/2012 | WO2012076823A1 Intra-tissue in vitro diagnosis method for diagnosing brain tumours |
06/14/2012 | WO2012076821A1 Inter-tissue in vitro diagnosis method for diagnosing brain tumours |
06/14/2012 | WO2012076794A1 Functionalization processes and reactants used in such processes using an isatoic anhydride or a derivative thereof, biological molecules thus treated and kits |
06/14/2012 | WO2012076734A1 Method for the diagnosis, prognosis and monitoring of muscular degeneration |
06/14/2012 | WO2012076650A1 Marker for carcinoma |
06/14/2012 | WO2012076431A1 Pathogen sensor |
06/14/2012 | WO2012076350A1 A biosensor using impedimetric real-time monitoring |
06/14/2012 | WO2012076349A1 Heat-transfer resistance based analysis bioparticles |
06/14/2012 | WO2012075959A1 Hemi-methylation linker and use thereof |
06/14/2012 | WO2012075912A1 Sub-totipotent stem cell product and apparent hereditary modifying label thereof |
06/14/2012 | WO2012075644A1 Method for manufacturing fluid-detecting test piece |
06/14/2012 | WO2012075636A1 Tags of epigenetic modification for predicting differential potential of stem cells |
06/14/2012 | WO2012075599A1 Sex discernment by real-time pcr in coho salmon |
06/14/2012 | WO2012075597A1 Determination of the virulence of infectious pancreatic necrosis virus in fish |
06/14/2012 | WO2012075591A1 In vitro mitochondrial function test (mft) and uses thereof |
06/14/2012 | WO2012058625A3 Assays and kits to determine galactocerebrosidase activity on solid support |
06/14/2012 | WO2012047099A3 Method for extracting dna from nematodes and plant cells |
06/14/2012 | WO2012044933A3 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy |
06/14/2012 | WO2012040603A3 Use of diazolidinyl urea for anti-clumping of biological samples |
06/14/2012 | WO2012037937A3 Method for detecting, differentiating, and quantifying t cell populations by means of reverse transcription quantitative real-time pcr (rt-qpcr) technology |
06/14/2012 | WO2012034117A3 Enzyme co-factor enhancement of biosensor performance |
06/14/2012 | WO2012033875A3 Compositions and methods for nucleic acid based diagnostic assays for variable sequence targets |
06/14/2012 | WO2012033666A3 Electronic and fluidic interface |
06/14/2012 | WO2012033324A3 Novel biological detection method for dioxins in serum, and a diagnostic use therefor in metabolic syndrome and related conditions |
06/14/2012 | WO2012031207A3 Methods and compositions for correlating genetic markers with prostate cancer risk |
06/14/2012 | WO2012030956A3 Mirna detection of pancreatic cancer |
06/14/2012 | WO2012030840A9 Gene signatures for cancer diagnosis and prognosis |
06/14/2012 | WO2012030136A3 Oligonucleotides for detecting listeria spp. and use thereof |
06/14/2012 | WO2012027747A3 Asynchronous magnetic bead rotation sensing systems and methods |
06/14/2012 | WO2012023138A3 Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer |
06/14/2012 | WO2012021308A3 Method for retrovirus removal |
06/14/2012 | WO2012015765A3 Method for using gene expression to determine prognosis of prostate cancer |
06/14/2012 | WO2012012714A3 Methods of detecting neurological or neuropsychiatric diseases or conditions |
06/14/2012 | WO2012012694A3 Methods of detecting autoimmune or immune-related diseases or conditions |
06/14/2012 | WO2012012693A3 Methods for detecting signatures of disease or conditions in bodily fluids |
06/14/2012 | WO2012002775A4 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma |
06/14/2012 | WO2011149267A9 Primer set for selecting pmmov-resistant pepper varieties, method thereof, and kit thereof |
06/14/2012 | WO2011056060A8 Recombinant matrix protein of nipah virus |
06/14/2012 | WO2007149269A9 Methylation markers for early detection and prognosis of colon cancers |
06/14/2012 | US20120151622 Phytophthora resistance in sweet peppers |
06/14/2012 | US20120151621 Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants |
06/14/2012 | US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development |
06/14/2012 | US20120151609 Genetically Modified Rat Models for Pain |
06/14/2012 | US20120150032 Sequence Variants Associated with Prostate Specific Antigen Levels |
06/14/2012 | US20120150005 Analyte Sensors with a Sensing Surface Having Small Sensing Spots |
06/14/2012 | US20120149893 Modulation of eif4e-bp2 |
06/14/2012 | US20120149843 Nanofibers and morphology shifting micelles |
06/14/2012 | US20120149785 Method of estimating sepsis risk in an individual with infection |
06/14/2012 | US20120149765 Sgk1 as diagnostic and therapeutic target |
06/14/2012 | US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof |
06/14/2012 | US20120149757 Compositions and methods for modulation of smn2 splicing |
06/14/2012 | US20120149754 Methods for modulating the expression and aggregation of cag-expanded gene product in cells and methods for identifying agents useful for doing the same |
06/14/2012 | US20120149714 Effects of Inhibitors of FGFR3 on Gene Transcription |
06/14/2012 | US20120149668 Glucocorticoid receptor alleles and uses thereof |
06/14/2012 | US20120149651 Caveolin peptides and their use as therapeutics |
06/14/2012 | US20120149647 Methods for Assessing the Efficacy of Gemcitabine or Ara-C Treatment of Cancer Using Human Antigen R Levels |
06/14/2012 | US20120149645 Compositions and modulation of myocyte enhancer factor 2 (mef2) |
06/14/2012 | US20120149602 Method for making populations of defined nucleic acid molecules |
06/14/2012 | US20120149599 Combined rapid susceptibility assay and microorganism identification system |
06/14/2012 | US20120149598 Feeder cells for target cell induction |
06/14/2012 | US20120149597 Protein fragment complementation assays for high-throughput and high-content screening |
06/14/2012 | US20120149595 Markers for diagnosis of pulmonary inflammation and methods related thereto |
06/14/2012 | US20120149591 In vitro peptide expression library |
06/14/2012 | US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
06/14/2012 | US20120149587 Method for detecting nucleated cells |
06/14/2012 | US20120149586 Methods of predicting the risk of recurrence of cancer |
06/14/2012 | US20120149584 Methods of diagnosing and treating microbiome-associated disease using interaction network parameters |
06/14/2012 | US20120149581 Process of constructing oxidation-reduction nanomedicine quantum dots room temperature quantum bit networks |
06/14/2012 | US20120149576 Method for cultivating crop plant |
06/14/2012 | US20120149109 Modulation of transthyretin expression |
06/14/2012 | US20120149069 Methods and compositions for seamless cloning of nucleic acid molecules |
06/14/2012 | US20120149068 Methods and compositions for amplification of rna sequences |